Fatemeh Esmaeili - Concepedia

Author

Fatemeh Esmaeili

Tehran University of Medical Sciences ORCID

Also Known As

Esmaeili F, F. Esmaeili, Fatemeh Esmaeili

Publications

392

Citations

H-Index

Concepts

All Affiliations

Tehran University of Medical Sciences Shahid Beheshti University of Medical Sciences Shariati Hospital University of Turku Åbo Akademi University

About

Fatemeh Esmaeili is an author at Tehran University of Medical Sciences specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	145
2	Health Sciences	2	2	66
3	Cell Biology	2	2	68
4	Engineering	1	1	11
5	Public Health	1	1	39

Fatemeh Esmaeili

Publications

322

Citations

H-Index

Page 1

	Year	Citations
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer Hassan Yousefi, Majid Momeny, Seyed H. Ghaffari, Tumori Journal	2018	45
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells Majid Momeny, Hassan Yousefi, Haniyeh Eyvani, The International Journal of Biochemistry & Cell Biology MedicineInduces ApoptosisApoptosisImmunologyCell Death	2018	42
Analysis of trace elements in processed products of grapes and potential health risk assessment Roya Peirovi-Minaee, Ali Alami, Fatemeh Esmaeili, Environmental Science and Pollution Research Food ChemistryNutritionFood TraceabilityProcessed ProductsFood Analysis	2024	39
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells Majid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, Scientific Reports	2017	37
The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial Vahid Maleki, Mohammad Alizadeh, Fatemeh Esmaeili, Amino Acids Metabolic SyndromeNutritionDiabetes ManagementMedicineDiabetes	2020	30
The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial Fatemeh Esmaeili, Vahid Maleki, Sorayya Kheirouri, Canadian Journal of Diabetes Metabolic SyndromeMedicineDiabetesPhysiologyType 2	2020	27
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells Majid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, Cellular Oncology Pancreatic CancerMedicinePathologyTumor SuppressorOncology	2019	26
Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells Majid Momeny, Zivar Alishahi, Haniyeh Eyvani, Cellular Oncology Pancreatic CancerMedicinePharmacologyPathologyAnti-cancer Agent	2019	20
Development and Validation of a Stability-Indicating Method for the Quantitation of Paclitaxel in Pharmaceutical Dosage Forms Ali Mohammadi, Fatemeh Esmaeili, Rassoul Dinarvand, Journal of Chromatographic Science	2009	17
Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells Majid Momeny, Haniyeh Eyvani, Farinaz Barghi, Anti-Cancer Drugs	2018	17

Page 1